KPMA chairman calls for fair drug pricing policy

Published: 2007-10-30 06:59:00

Updated: 2007-10-30 06:59:00

Kim Chung-soo of the Korea Pharmaceutical Manufacturers Association (KPMA) said in a statement that the government should work out measures to encourage drug companies to develop and market as many new drugs as possible to reduce drug costs covered by National Health Insurance.

He said that lo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK